Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
Editor-in-Chief: Professor Frank Boeckler
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (5714)
- Volume 20, 2026 (482)
- Volume 19, 2025 (762)
- Volume 18, 2024 (430)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
0.06% Ropivacaine Combined with Double-Hole Dural Puncture Epidural Analgesia in Labor for Primiparous Women: A Prospective Randomized Controlled Trial
Piao G, Li H, Jin S, Feng L, Zhao Y, Jiang M, Zhou T, Jin M
Drug Design, Development and Therapy 2026, 20:617452
Published Date: 10 July 2026
Cataract as an Endpoint-Dependent Confounder in Trials of Neuroprotective Therapies for Glaucoma [Letter]
Yang D, Zou J
Drug Design, Development and Therapy 2026, 20:635506
Published Date: 10 July 2026
Ultrasound-Guided Femoral Nerve Block with Esketamine Adjuvant for Postoperative Analgesia in Total Knee Arthroplasty–A Randomized, Double-Blind, Controlled Trial
Cheng Z, Hong L, Wang Y, Wang P
Drug Design, Development and Therapy 2026, 20:609966
Published Date: 10 July 2026
Phase I Study Evaluating Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Recombinant Human Serum Albumin (rHSA) in Healthy Adults
Panuganti VK, Dundigalla MR, Grandhi VR, Khambhampaty S, Madala PK, Mohammad J, Shaik A, Shaik MB, KSSVV S, Sangeetham SK
Drug Design, Development and Therapy 2026, 20:598274
Published Date: 10 July 2026
Effects of Remimazolam Dose and Bolus Injection Rate on Hiccups During Painless Colonoscopy: A Double-Blind Randomized Clinical Trial [Response to Letter]
Lu Y, Wang X, Zou H, Shao C, Lai G, Ou S
Drug Design, Development and Therapy 2026, 20:632112
Published Date: 10 July 2026